Telmisartan (40mg) + Chlorthalidone (6.25mg) is manufactured by Glenmark Pharmaceuticals Ltd
Telma-CT 40/6.25 Tablet is a combination of two medicines:
This is available in a 1 Strip of 15 Tablet format with an MRP of ₹298.
If you experience any persistent or severe side effects, consult your doctor immediately.
It is unsafe to consume alcohol with Telma-CT 40/6.25 Tablet.
Telma-CT 40/6.25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Telma-CT 40/6.25 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Telma-CT 40/6.25 Tablet may be needed. Please consult your doctor. Use of Telma-CT 40/6.25 Tablet is not recommended in these patients.
Telma-CT 40/6.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Telma-CT 40/6.25 Tablet may be needed. Please consult your doctor. Use of Telma-CT 40/6.25 Tablet is not recommended in patients with severe liver disease.
Telma-CT 40/6.25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Telma-CT 40/6.25 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.














100% Genuine
Medicines
No
Return
Online
Payment Only
Glenmark Pharmaceuticals Ltd
100% Genuine
Medicines
No
Return
Online
Payment Only
Glenmark Pharmaceuticals Ltd